Evidence map›Paper›PMID 37150856›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Deep Penetrating and Sensitive Targeted Magnetic Particle Imaging and Photothermal Therapy of Early-Stage Glioblastoma Based on a Biomimetic Nanoplatform.

Xiazi Huang, Hui Hui, Wenting Shang, Pengli Gao, Yingying Zhou, Weiran Pang, Chi Man Woo, Jie Tian, Puxiang Lai

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Stimuli-Responsive Materials for Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Self-Assembled Aza-Boron-Dipyrromethene-Based HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xiazi HuangDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 000000, China.ORCID 0000-0003-1679-3503
Hui HuiCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.ORCID 0000-0002-6732-4232
Wenting ShangCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Pengli GaoCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Yingying ZhouDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 000000, China.
Weiran PangDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 000000, China.
Chi Man WooDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 000000, China.
Jie TianCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.ORCID 0000-0003-0498-0432
Puxiang LaiDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 000000, China.ORCID 0000-0003-4811-2012
Hong Kong Polytechnic University · HKChinese Academy of Sciences · CN

Funding

Beijing Natural Science Foundation JQ22023CAS Youth Innovation Promotion Association under Grant Y2022055Guangdong Key Research and Development Program of China 2021B0101420005Guangdong Science and Technology Commission 2019BT02X105Hong Kong Innovation and Technology Commission GHP/043/19SZHong Kong Innovation and Technology Commission GHP/044/19GDHong Kong Polytechnic University P0038180Hong Kong Polytechnic University P0039517Hong Kong Polytechnic University P0043485Hong Kong Research Grant Council 15217721Hong Kong Research Grant Council C7074-21GFHong Kong Research Grant Council R5029-19National Natural Science Foundation of China 62027901National Natural Science Foundation of China 81227901National Natural Science Foundation of China 81671851National Natural Science Foundation of China 81930048Project of High-Level Talents Team Introduction in Zhuhai City Zhuhai HLHPTP201703
6 · The paper itself

Abstract

Early diagnosis can effectively improve the survival of glioblastoma multiforme (GBM). A specific imaging technique that is simultaneously deep penetrating and sensitive to small tissue changes is desired to identify GBM. Due to its excellent features in signal contrast, detection sensitivity, and none or little attenuation in tissue, magnetic particle imaging (MPI) possesses great potential in cancer diagnosis, especially when the imaging modality is equipped with specifically targeted nanoprobes. However, when gliomas are small, the blood-brain barrier (BBB) is complete and prevents nanoprobes from entering the brain, which negates the theranostic effect. This study proposes a biomimetic nanoplatform that assist the MPI tracers in breaking through the BBB and then demonstrate a targeted and sensitive diagnosis of GBM. Afterward, the photothermal therapy and immune regulation show an excellent therapeutic effect on the GBM. It is experimentally confirmed that the MPI signal does not decay with tissue depth and shows excellent sensitivity for thousands-cells. Only small animals are conducted in this study due to the limitations of the current commercial MPI scanner, however, this research theoretically enables large animal and human studies, which encourages a promising pathway toward the noninvasive diagnosis of early-stage GBM in clinics.

Indexed as

GlioblastomaAnimalsBiomimeticsCell Line, TumorHumansMagnetic PhenomenaPhotothermal Therapybiomimetic nanoplatformbrain-blood-barrier breakingcancer diagnosisglioblastoma multiformemagnetic particle imaging

Identifiers

PMID37150856
PMCPMC10323639
OpenAlexW4375855810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.